The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Alfieri Michael since 2018.
This trader's CIK number is 1744687.
At the time of last reporting, Alfieri Michael was the Principal Financial Officer of Aldeyra Therapeutics, Inc.. (stock ticker symbol ALDX).
Also see all insider trading activities at Aldeyra Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | GNCA | 10,000 | $5,400 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2025 | ALDX | 2,500 | $13,250 | 0 | $0 | 0 | $0 |
1. Genocea Biosciences, Inc. (GNCA)
2. Aldeyra Therapeutics, Inc. (ALDX)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-09-13 | GNCA | Buy | 10,000 | .54 | 5,400 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2025-08-13 | ALDX | Buy | 2,500 | 5.30 | 13,250 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Alfieri Michael (Principal Financial Officer of Aldeyra Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.